Antibody-drug conjugates (ADCs) are transforming oncology with their ability to deliver potent cytotoxic agents directly to ...
Welcome to Valion Bio, Inc.'s conference call to discuss first quarter 2026 financial results. This call has been prerecorded. The call is being webcast, and the replay will be available on the ...
Headquartered in Mississauga, Ontario, Diteba is exceptionally well suited to serve as the anchor laboratory for the program, supported by a robust Quality Management System and a multidisciplinary ...
Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for CJC-1295 ...
The US Food and Drug Administration (FDA) has released a final guidance document with immediate effect advising sponsors on ...
Regulators increasingly want medical device manufacturers to begin with a more precise understanding of their product's ...
Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced that it has entered into a development and manufacturing agreement with MPP Group LLC ("MPP"), a Mequon, ...
Vibrational spectroscopy uses visible and infrared light to reveal molecular-level details, enabling high-quality material ...
Artificial intelligence shows promise for improving care for peripheral artery disease through earlier detection, improved ...
Vietnam Investment Review on MSN
Bora navigates transitional Q1 2026 sets foundation for rest of year
HONG KONG SAR - Media OutReach Newswire – 13 May 2026 – Bora Pharmaceuticals ("Bora"; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 1Q2026 and provides ...
CEPI uses AI to achieve its vaccine goal, aiming to develop safe, effective vaccines within 100 days of identifying pandemic ...
Part 1 of this series focused on diligence and opinions. Patent prosecution is undergoing the same transition: AI has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results